Access Resources
1911 - 1920 of 7540 Results
Title
Year
- Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson’s Disease From Clinical and Genetic Data2022RESTRICTEDTitle: Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson’s Disease From Clinical and Genetic DataJournal Name: IEEE Open Journal of Engineering in Medicine and BiologyPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #:Start Page: 96End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1109/ojemb.2022.3178295Best OA location URL: https://ieeexplore.ieee.org/ielx7/8782705/8937520/09783181.pdfCitation Count: 2
- Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cells2022RESTRICTEDTitle: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cellsJournal Name: Open BiologyPublisher: The Royal SocietyVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.210264Best OA location URL: https://doi.org/10.1098/rsob.210264Citation Count: 21
- Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex2022RESTRICTEDTitle: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complexJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 1Start Page: 44End Page: 59.e6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012Best OA location URL: http://www.cell.com/article/S1097276521009916/pdfCitation Count: 42
- Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography2022RESTRICTEDTitle: Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topographyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 35Issue #:Start Page: 103080End Page: 103080Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103080Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103080Citation Count: 12
- Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?2022RESTRICTEDTitle: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Journal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 51Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1093/ageing/afab242Best OA location URL: https://academic.oup.com/ageing/article-pdf/51/1/afab242/42261496/afab242.pdfCitation Count: 7
-
RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 14
- NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network2022RESTRICTEDTitle: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural networkJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103250End Page: 103250Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103250Citation Count: 2
- Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study2022RESTRICTEDTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398229Citation Count: 12
-
RESTRICTEDTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 0
- POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA2022RESTRICTEDTitle: POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USAJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734609Citation Count: 2